For InvestorsAntares Pharma: Making Medicines Feel Better

Press Release Archive

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

2016

07 Jan 2016
Antares Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference

26 Jan 2016
Antares Pharma Announces CEO Transition

01 Mar 2016
Antares Pharma to Host Fourth Quarter and Full Year 2015 Operating and Financial Results Call

08 Mar 2016
Antares Pharma Reports Fourth Quarter and Full Year 2015 Financial and Operating Results

16 Mar 2016
Antares Announces Completion of the 52 week Quickshot Phase 3 Study in Testosterone Deficient Men

29 Mar 2016
Additional dosage strengths of Otrexup Methotrexate Injection approved by the FDA

05 Apr 2016
Antares Pharma Discloses "Pen 1" Development Project as Teriparatide

25 Apr 2016
Otrexup.com website awarded a Bronze Horizon Interactive Award

27 Apr 2016
Antares Pharma to Present at the Deutsche Bank Securities,INC. 41st Annual Healthcare Conference

02 May 2016
Antares Pharma to Host First Quarter Operating and Financial Results Conference Call

09 May 2016
Antares Pharma Reports First Quarter 2016 Financial and Operating Results

24 May 2016
Antares Pharma will be attending the BIO International Convention June 6-9 in San Francisco. We look forward to meeting with you at our exhibition booth #5778!

01 Jun 2016
Antares Pharma Announces Update to Quickshot Testosterone Program

23 Jun 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product

27 Jun 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States

02 Aug 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and Conference Call

09 Aug 2016
Antares Pharma Reports Second Quarter 2016 Operating And Financial Results

20 Sep 2016
Antares Pharma to Present at the Ladenberg Thalmann 2016 Healthcare Conference

22 Sep 2016
Antares Pharma Announces Completion of the Quickshot Testosterone Clinical Program

28 Oct 2016
ANTARES PHARMA ANNOUNCES MULTIPLE PRESENTATIONS AT THE SEXUAL MEDICINE SOCIETY SCIENTIFIC ANNUAL MEETING

01 Nov 2016
ANTARES PHARMA APPOINTS FRED M. POWELL, SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

02 Nov 2016
Antares Pharma Announces Presentations at the Sexual Medicine Society Scientific Annual Meeting

03 Nov 2016
Antares Pharma to Report Third Quarter Financial and Operating Results and Host Webcast and Conference Call

09 Nov 2016
ANTARES PHARMA REPORTS THIRD QUARTER 2016 FINANCIAL AND OPERATING RESULTS

10 Nov 2016
Antares Pharma to Present at the Jefferies 2016 Global Healthcare Conference

23 Nov 2016
Antares Pharma to Present at the 28th Annual Piper Jaffray Healthcare Conference

21 Dec 2016
Antares Pharma Announces Submission of New Drug Application for Quickshot Testosterone

19 Dec 2016
ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA’S DECENTRALIZED PROCEDURE FOR TERIPARATIDE INJECTION IN EUROPE

For Investors

Press Archive

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013


  • Sign up for breaking news on ATRS

    * indicates required